Vectors Research Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,025
| Closed | -$987K | – | 135 |
|
|
2024
Q1 | $987K | Sell |
1,025
-39
| -4% | -$37.6K | 0.28% | 80 |
|
|
2023
Q4 | $935K | Sell |
1,064
-12
| -1% | -$10.5K | 0.26% | 79 |
|
|
2023
Q3 | $849K | Sell |
1,076
-13
| -1% | -$10.3K | 0.28% | 75 |
|
|
2023
Q2 | $782K | Sell |
1,089
-73
| -6% | -$52.4K | 0.22% | 85 |
|
|
2023
Q1 | $955K | Sell |
1,162
-8
| -0.7% | -$6.58K | 0.25% | 79 |
|
|
2022
Q4 | $844K | Sell |
1,170
-41
| -3% | -$29.6K | 0.22% | 84 |
|
|
2022
Q3 | $834K | Sell |
1,211
-18
| -1% | -$12.4K | 0.24% | 79 |
|
|
2022
Q2 | $726K | Sell |
1,229
-38
| -3% | -$22.4K | 0.18% | 92 |
|
|
2022
Q1 | $885K | Sell |
1,267
-20
| -2% | -$14K | 0.19% | 90 |
|
|
2021
Q4 | $813K | Buy |
1,287
+39
| +3% | +$24.6K | 0.17% | 99 |
|
|
2021
Q3 | $755K | Buy |
1,248
+36
| +3% | +$21.8K | 0.18% | 99 |
|
|
2021
Q2 | $677K | Buy |
1,212
+37
| +3% | +$20.7K | 0.17% | 103 |
|
|
2021
Q1 | $556K | Buy |
+1,175
| New | +$556K | 0.15% | 107 |
|
|
2020
Q3 | – | Sell |
-25
| Closed | -$16K | – | 454 |
|
|
2020
Q2 | $16K | Hold |
25
| – | – | 0.01% | 253 |
|
|
2020
Q1 | $12K | Hold |
25
| – | – | 0.01% | 282 |
|
|
2019
Q4 | $9K | Buy |
+25
| New | +$9K | ﹤0.01% | 365 |
|